| histone h3 k9 methylation | GO:0051567 | 17 | 1.000 | |
| histone lysine methylation | GO:0034968 | 50 | 0.999 | |
| protein methylation | GO:0006479 | 81 | 0.999 | |
| positive regulation of histone h3 k27 methylation | GO:0061087 | 4 | 0.998 | |
| methylation | GO:0032259 | 134 | 0.998 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.997 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.995 | |
| histone methylation | GO:0016571 | 71 | 0.994 | |
| negative regulation of histone methylation | GO:0031061 | 10 | 0.993 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.991 | |
| dna modification | GO:0006304 | 50 | 0.987 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.987 | |
| dna metabolic process | GO:0006259 | 303 | 0.985 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.983 | |
| protein alkylation | GO:0008213 | 81 | 0.982 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.979 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.975 | |
| cell division | GO:0051301 | 120 | 0.972 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.971 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.970 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.966 | |
| histone modification | GO:0016570 | 159 | 0.954 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.948 | |
| chromatin organization | GO:0006325 | 206 | 0.947 | |
| chromatin modification | GO:0016568 | 187 | 0.945 | |
| gene silencing | GO:0016458 | 38 | 0.938 | |
| dna methylation | GO:0006306 | 43 | 0.938 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.932 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.931 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.925 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.923 | |
| maintenance of cell number | GO:0098727 | 3 | 0.922 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.916 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.914 | |
| macromolecule methylation | GO:0043414 | 120 | 0.904 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.900 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.899 | |
| histone acetylation | GO:0016573 | 41 | 0.894 | |
| regionalization | GO:0003002 | 337 | 0.893 | |
| circadian rhythm | GO:0007623 | 114 | 0.891 | |
| rhythmic process | GO:0048511 | 174 | 0.849 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.809 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.807 | |
| dna alkylation | GO:0006305 | 43 | 0.795 | |
| male meiosis i | GO:0007141 | 16 | 0.784 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.781 | |
| male gamete generation | GO:0048232 | 285 | 0.770 | |
| dna repair | GO:0006281 | 107 | 0.754 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.750 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.726 | |
| histone h3 k9 acetylation | GO:0043970 | 5 | 0.719 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.718 | |
| regulation of histone h3 k27 methylation | GO:0061085 | 6 | 0.707 | |
| chromatin silencing | GO:0006342 | 15 | 0.701 | |
| protein acylation | GO:0043543 | 64 | 0.696 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.690 | |
| genetic imprinting | GO:0071514 | 27 | 0.685 | |
| chromatin assembly | GO:0031497 | 13 | 0.684 | |
| cytokinesis | GO:0000910 | 17 | 0.659 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.653 | |
| organelle fission | GO:0048285 | 170 | 0.639 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.609 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.594 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.576 | |
| histone h3 k27 methylation | GO:0070734 | 11 | 0.575 | |
| positive regulation of histone h3 k4 methylation | GO:0051571 | 5 | 0.560 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.558 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.540 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.535 | |
| spermatogenesis | GO:0007283 | 284 | 0.535 | |
| male meiosis | GO:0007140 | 37 | 0.518 | |
| rna interference | GO:0016246 | 2 | 0.502 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.493 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.484 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.482 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.475 | |
| protein localization to organelle | GO:0033365 | 185 | 0.471 | |
| regulation of histone modification | GO:0031056 | 56 | 0.457 | |
| dna packaging | GO:0006323 | 30 | 0.443 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.434 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.417 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.411 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.405 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.395 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.392 | |
| dendrite development | GO:0016358 | 115 | 0.378 | Fly |
| digestive system development | GO:0055123 | 200 | 0.376 | |
| protein maturation | GO:0051604 | 176 | 0.375 | |
| nucleosome positioning | GO:0016584 | 4 | 0.366 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.365 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.365 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.356 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.339 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.339 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.334 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.321 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.319 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.314 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.311 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.308 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.308 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.305 | |
| dna hypermethylation | GO:0044026 | 3 | 0.300 | |
| heterochromatin organization | GO:0070828 | 4 | 0.298 | |
| stem cell development | GO:0048864 | 219 | 0.291 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.290 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.281 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.281 | |
| protein catabolic process | GO:0030163 | 221 | 0.274 | |
| response to oxidative stress | GO:0006979 | 123 | 0.273 | |
| response to radiation | GO:0009314 | 165 | 0.273 | Fly |
| dna templated transcription termination | GO:0006353 | 4 | 0.272 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.252 | |
| microtubule based process | GO:0007017 | 236 | 0.250 | |
| bone development | GO:0060348 | 120 | 0.247 | |
| protein processing | GO:0016485 | 163 | 0.245 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.242 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.239 | |
| axonogenesis | GO:0007409 | 274 | 0.238 | |
| segmentation | GO:0035282 | 93 | 0.238 | |
| negative regulation of retinoic acid receptor signaling pathway | GO:0048387 | 5 | 0.237 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.233 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.231 | |
| mapk cascade | GO:0000165 | 281 | 0.229 | |
| gene silencing by rna | GO:0031047 | 19 | 0.225 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.225 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.220 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.220 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.212 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.211 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.209 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.206 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.199 | |
| rna localization | GO:0006403 | 23 | 0.198 | |
| regulation of cell division | GO:0051302 | 76 | 0.198 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.191 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.189 | |
| negative regulation of histone modification | GO:0031057 | 18 | 0.189 | |
| positive regulation of dna templated transcription initiation | GO:2000144 | 5 | 0.185 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.184 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.180 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.180 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.179 | |
| dna replication independent nucleosome assembly | GO:0006336 | 1 | 0.176 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.172 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.172 | |
| negative regulation of histone h3 k9 methylation | GO:0051573 | 4 | 0.172 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.170 | |
| spermatid development | GO:0007286 | 108 | 0.170 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.170 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.168 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.166 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.165 | |
| regulation of protein processing | GO:0070613 | 96 | 0.165 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.162 | |
| dna replication | GO:0006260 | 52 | 0.158 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.156 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.155 | |
| female gamete generation | GO:0007292 | 74 | 0.153 | |
| oocyte axis specification | GO:0007309 | 2 | 0.152 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.150 | |
| gonad development | GO:0008406 | 141 | 0.149 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.149 | |
| organelle assembly | GO:0070925 | 177 | 0.149 | |
| mrna transport | GO:0051028 | 13 | 0.148 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.148 | |
| regulation of dna replication | GO:0006275 | 17 | 0.148 | |
| regulation of system process | GO:0044057 | 200 | 0.147 | |
| metencephalon development | GO:0022037 | 89 | 0.140 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.138 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.136 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.135 | |
| nucleosome assembly | GO:0006334 | 7 | 0.134 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.134 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.131 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.130 | |
| dna conformation change | GO:0071103 | 37 | 0.128 | |
| response to light stimulus | GO:0009416 | 135 | 0.128 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.127 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.125 | |
| negative regulation of transcription elongation from rna polymerase ii promoter | GO:0034244 | 6 | 0.124 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.124 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.123 | |
| response to inorganic substance | GO:0010035 | 96 | 0.123 | |
| stem cell differentiation | GO:0048863 | 268 | 0.118 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.117 | |
| nuclear division | GO:0000280 | 158 | 0.116 | |
| meiosis i | GO:0007127 | 60 | 0.112 | |
| hindbrain development | GO:0030902 | 128 | 0.112 | |
| cation homeostasis | GO:0055080 | 212 | 0.110 | |
| stem cell maintenance | GO:0019827 | 130 | 0.110 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.110 | |
| gliogenesis | GO:0042063 | 141 | 0.109 | |
| axon guidance | GO:0007411 | 141 | 0.107 | |
| cellular homeostasis | GO:0019725 | 240 | 0.107 | |
| myotube differentiation | GO:0014902 | 105 | 0.103 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.103 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.103 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.102 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.102 | |
| double strand break repair | GO:0006302 | 48 | 0.101 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.101 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.100 | |
| cellular response to radiation | GO:0071478 | 28 | 0.100 | |
| microtubule organizing center organization | GO:0031023 | 28 | 0.098 | |
| placenta development | GO:0001890 | 140 | 0.098 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.097 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.096 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.094 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.093 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.092 | |
| chromosome segregation | GO:0007059 | 48 | 0.090 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.090 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.089 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.088 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.088 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.087 | |
| fat cell differentiation | GO:0045444 | 160 | 0.087 | |
| circulatory system process | GO:0003013 | 197 | 0.086 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.085 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.085 | |
| dna recombination | GO:0006310 | 92 | 0.085 | |
| regulation of synapse structural plasticity | GO:0051823 | 4 | 0.085 | |
| dna templated transcription initiation | GO:0006352 | 13 | 0.084 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.083 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.083 | |
| atp catabolic process | GO:0006200 | 55 | 0.083 | |
| oocyte development | GO:0048599 | 33 | 0.081 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.081 | Fly |
| negative regulation of dna templated transcription elongation | GO:0032785 | 6 | 0.081 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.080 | |
| body morphogenesis | GO:0010171 | 45 | 0.080 | |
| developmental maturation | GO:0021700 | 193 | 0.079 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.078 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.077 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.076 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.076 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.075 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.075 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.075 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.073 | |
| camera type eye development | GO:0043010 | 266 | 0.073 | |
| ossification | GO:0001503 | 216 | 0.073 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.072 | |
| rna 3 end processing | GO:0031123 | 20 | 0.071 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.071 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.071 | |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.070 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.070 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.069 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.068 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.068 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.067 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.067 | |
| termination of rna polymerase i transcription | GO:0006363 | 2 | 0.067 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.067 | |
| endonucleolytic cleavage involved in rrna processing | GO:0000478 | 1 | 0.067 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.067 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.066 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.066 | |
| skeletal system development | GO:0001501 | 356 | 0.066 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.065 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.065 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.064 | |
| compound eye development | GO:0048749 | 1 | 0.064 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.064 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.064 | |
| regulation of protein stability | GO:0031647 | 52 | 0.063 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.063 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.063 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.062 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.062 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.062 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.062 | |
| pole plasm assembly | GO:0007315 | 2 | 0.062 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.061 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.060 | |
| translation | GO:0006412 | 93 | 0.060 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.060 | |
| negative regulation of fatty acid metabolic process | GO:0045922 | 10 | 0.060 | |
| regeneration | GO:0031099 | 38 | 0.059 | |
| cation transport | GO:0006812 | 399 | 0.059 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.059 | |
| neural tube development | GO:0021915 | 160 | 0.059 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.059 | |
| genitalia development | GO:0048806 | 37 | 0.058 | |
| locomotory behavior | GO:0007626 | 195 | 0.058 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.058 | |
| centrosome organization | GO:0051297 | 26 | 0.057 | |
| defense response to other organism | GO:0098542 | 197 | 0.057 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.056 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.056 | |
| cell growth | GO:0016049 | 130 | 0.056 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.056 | |
| intracellular protein transport | GO:0006886 | 204 | 0.056 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.056 | |
| multicellular organism growth | GO:0035264 | 161 | 0.056 | |
| response to alkaloid | GO:0043279 | 34 | 0.055 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.055 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.055 | |
| telomere maintenance | GO:0000723 | 19 | 0.054 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.054 | |
| wound healing | GO:0042060 | 157 | 0.053 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.053 | |
| establishment of rna localization | GO:0051236 | 18 | 0.053 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.052 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.052 | |
| response to osmotic stress | GO:0006970 | 21 | 0.051 | |
| digestive tract development | GO:0048565 | 190 | 0.051 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.051 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.050 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.050 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.050 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.050 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.050 | |
| rna processing | GO:0006396 | 105 | 0.050 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.049 | |
| germ line stem cell division | GO:0042078 | 2 | 0.049 | |
| gastrulation | GO:0007369 | 116 | 0.048 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.048 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.048 | |
| negative regulation of striated muscle cell differentiation | GO:0051154 | 14 | 0.047 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.047 | |
| regulation of transcription elongation from rna polymerase ii promoter | GO:0034243 | 9 | 0.047 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.046 | |
| muscle contraction | GO:0006936 | 101 | 0.045 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.045 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.045 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.045 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.045 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.044 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.044 | |
| histone mrna metabolic process | GO:0008334 | 3 | 0.043 | |
| gland development | GO:0048732 | 330 | 0.043 | |
| lateral inhibition | GO:0046331 | 1 | 0.043 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.043 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.043 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.043 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.043 | |
| nuclear import | GO:0051170 | 95 | 0.042 | |
| rna splicing | GO:0008380 | 54 | 0.042 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.042 | |
| germ cell development | GO:0007281 | 185 | 0.042 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.041 | |
| spermatid differentiation | GO:0048515 | 115 | 0.041 | |
| regulation of metaphase anaphase transition of cell cycle | GO:1902099 | 9 | 0.040 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.040 | |
| oogenesis | GO:0048477 | 56 | 0.040 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 8 | 0.040 | |
| positive regulation of growth | GO:0045927 | 104 | 0.040 | |
| protein modification by small protein removal | GO:0070646 | 21 | 0.040 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.039 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.039 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.039 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.039 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.038 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.038 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.038 | |
| negative regulation of proteolysis involved in cellular protein catabolic process | GO:1903051 | 22 | 0.038 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.038 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.038 | |
| dna endoreduplication | GO:0042023 | 4 | 0.038 | |
| membrane organization | GO:0061024 | 245 | 0.038 | |
| response to growth factor | GO:0070848 | 198 | 0.037 | |
| nucleus localization | GO:0051647 | 20 | 0.036 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.036 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.036 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.036 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.036 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.035 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.035 | |
| protein import into nucleus | GO:0006606 | 95 | 0.035 | |
| response to caffeine | GO:0031000 | 6 | 0.035 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.035 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.034 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.034 | |
| protein deacylation | GO:0035601 | 36 | 0.034 | |
| atp metabolic process | GO:0046034 | 75 | 0.034 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.034 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.034 | |
| regulation of dna templated transcription initiation | GO:2000142 | 7 | 0.033 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.033 | |
| rna polyadenylation | GO:0043631 | 6 | 0.033 | |
| protein deacetylation | GO:0006476 | 32 | 0.033 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.033 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.032 | |
| determination of adult lifespan | GO:0008340 | 11 | 0.032 | |
| regulation of cell activation | GO:0050865 | 289 | 0.032 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.032 | |
| amine metabolic process | GO:0009308 | 45 | 0.032 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.032 | |
| ribonucleoprotein complex localization | GO:0071166 | 1 | 0.032 | |
| cell aging | GO:0007569 | 35 | 0.031 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.031 | |
| negative regulation of growth | GO:0045926 | 99 | 0.031 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.031 | |
| maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna | GO:0000466 | 1 | 0.030 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.030 | |
| oocyte differentiation | GO:0009994 | 35 | 0.030 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.029 | |
| dna dependent dna replication | GO:0006261 | 24 | 0.029 | |
| actin filament organization | GO:0007015 | 113 | 0.029 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.029 | |
| embryonic placenta development | GO:0001892 | 98 | 0.029 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.029 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.029 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.028 | |
| response to amino acid | GO:0043200 | 37 | 0.028 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.028 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.028 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.028 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.028 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.028 | |
| cerebellum development | GO:0021549 | 77 | 0.028 | |
| maintenance of location | GO:0051235 | 89 | 0.028 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.028 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.028 | |
| innate immune response | GO:0045087 | 157 | 0.028 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.027 | |
| epidermis development | GO:0008544 | 187 | 0.027 | |
| chromosome organization involved in meiosis | GO:0070192 | 39 | 0.027 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.027 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.027 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.027 | |
| dna catabolic process | GO:0006308 | 19 | 0.027 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.027 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.026 | |
| blood circulation | GO:0008015 | 195 | 0.026 | |
| chemotaxis | GO:0006935 | 247 | 0.026 | |
| regulation of retinoic acid receptor signaling pathway | GO:0048385 | 7 | 0.026 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.026 | |
| nucleus organization | GO:0006997 | 45 | 0.026 | |
| defense response to fungus | GO:0050832 | 12 | 0.026 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.026 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.026 | |
| mitochondrion organization | GO:0007005 | 134 | 0.026 | |
| regulation of protein transport | GO:0051223 | 163 | 0.026 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.026 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.025 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.025 | |
| response to estrogen | GO:0043627 | 24 | 0.025 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.025 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.025 | |
| heart process | GO:0003015 | 94 | 0.024 | |
| oocyte construction | GO:0007308 | 2 | 0.024 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.024 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.024 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.024 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.024 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.024 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.024 | |
| positive regulation of g1 s transition of mitotic cell cycle | GO:1900087 | 9 | 0.024 | |
| microtubule sliding | GO:0051012 | 1 | 0.024 | |
| phagocytosis | GO:0006909 | 66 | 0.023 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.023 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.023 | |
| endonucleolytic cleavage of tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna | GO:0000479 | 1 | 0.023 | |
| response to acid chemical | GO:0001101 | 111 | 0.023 | |
| negative regulation of epidermal cell differentiation | GO:0045605 | 7 | 0.023 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.023 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.023 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.023 | |
| regulation of protein localization | GO:0032880 | 231 | 0.023 | |
| nucleobase containing compound transport | GO:0015931 | 27 | 0.023 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.023 | |
| membrane depolarization | GO:0051899 | 64 | 0.022 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.022 | |
| endocytosis | GO:0006897 | 168 | 0.022 | |
| cell maturation | GO:0048469 | 127 | 0.022 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.022 | |
| transcription initiation from rna polymerase ii promoter | GO:0006367 | 8 | 0.022 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.022 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.022 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.022 | |
| skin development | GO:0043588 | 220 | 0.022 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.021 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.021 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.021 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.021 | |
| response to purine containing compound | GO:0014074 | 28 | 0.021 | |
| protein localization to chromatin | GO:0071168 | 3 | 0.021 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.021 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.021 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.021 | |
| b cell activation | GO:0042113 | 161 | 0.021 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.021 | |
